Clinical Research Directory
Browse clinical research sites, groups, and studies.
Metabolism, Excretion, and Mass Balance Study of Quemliclustat in Healthy Adult Participants (ARC-24)
Sponsor: Arcus Biosciences, Inc.
Summary
The purpose of the study is to investigate the routes of elimination and overall mass balance of 100 mg quemliclustat containing 75 μCi \[14C\] following a single IV infusion of \[14C\]-quemliclustat in healthy adult male participants, and to quantify total radioactivity (TRA) in plasma, whole blood, urine, and feces.
Official title: A Phase 1, Open-Label Study to Characterize the Metabolism, Excretion, and Mass Balance of a Single Intravenous Dose of 100 mg Containing 75 µCi of [14C]-Quemliclustat in Healthy Adult Male Participants
Key Details
Gender
MALE
Age Range
19 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
8
Start Date
2026-02-03
Completion Date
2026-04
Last Updated
2026-03-04
Healthy Volunteers
Yes
Conditions
Interventions
Quemliclustat
Administered as specified in the treatment arm
Locations (1)
Celerion
Lincoln, Nebraska, United States